| P50 | author | Xiankun Zeng | Q64878247 |
| | Carl I Shaia | Q86080278 |
| P2093 | author name string | E R Wilkinson | |
| | K A Cashman | |
| | T M Bell | |
| | J J Bearss | |
| | M E Mattix | |
| | G C Donnelly | |
| | J D Shamblin | |
| | S P Honnold | |
| | K A Koistinen | |
| | C D Blancett | |
| P2860 | cites work | Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations | Q40562995 |
| | Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses | Q40625399 |
| | Acute sensorineural deafness in Lassa fever | Q40757577 |
| | A case-control study of the clinical diagnosis and course of Lassa fever | Q40798873 |
| | Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin | Q40861784 |
| | The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. | Q47325546 |
| | Pathogenesis of Lassa fever | Q24613450 |
| | Monitoring of clinical and laboratory data in two cases of imported Lassa fever | Q32061750 |
| | Pathology of experimental Machupo virus infection, Chicava strain, in cynomolgus macaques (Macaca fascicularis) by intramuscular and aerosol exposure | Q33416246 |
| | Pathogenesis of Bolivian Hemorrhagic Fever in Guinea Pigs | Q33424119 |
| | Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone | Q33621077 |
| | Lassa fever: epidemiology, clinical features, and social consequences | Q33822092 |
| | Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses | Q33964796 |
| | Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells | Q33976118 |
| | Establishing efficacy of human products using animals: the US food and drug administration's "animal rule". | Q34121007 |
| | Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response. | Q34626030 |
| | Clinical virology of Lassa fever in hospitalized patients | Q34692528 |
| | New opportunities for field research on the pathogenesis and treatment of Lassa fever | Q34744278 |
| | Pathogenesis of Lassa fever in cynomolgus macaques | Q35014564 |
| | Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. | Q35826698 |
| | Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection | Q35843254 |
| | Evaluation of Lassa antiviral compound ST-193 in a guinea pig model | Q35870592 |
| | The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset | Q36146469 |
| | Pathogenesis of viral hemorrhagic fever | Q36162873 |
| | Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques | Q40309258 |
| | Imported Lassa fever in Germany: surveillance and management of contact persons | Q40559139 |
| P433 | issue | 3 | |
| P921 | main subject | Lassa virus | Q1806636 |
| P304 | page(s) | 549-562 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Veterinary Pathology | Q7923710 |
| P1476 | title | Temporal Progression of Lesions in Guinea Pigs Infected With Lassa Virus | |
| P478 | volume | 54 | |